Inside informationEnglish
Amoéba obtains market authorisation in the United States for its AXPERA biocontrol solution
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- Amoeba
- Filed
- 16/10/2025, 18:00
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 076720_20251016